Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene represents a pseudogene for U6 small nuclear RNA. U6 snRNA itself is an essential component of the spliceosome, participating in the splicing of pre-mRNA by forming complexes with other snRNAs and proteins for intron excision. However, RNU6-1271P does not encode a functional RNA; it is an inactive genetic element formed by duplication or retrotransposition of the U6 snRNA gene, and it generally lacks biological function in humans. Its presence indicates evolutionary events and the high copy number of snRNA genes but has no direct relevance for drug discovery, clinical targeting, or disease biology. The entry RNU6-1271P should not be considered a valid target for pharmacological interventions, nor is it a biomarker for therapeutic or diagnostic applications. U6 snRNA itself is highly conserved and essential in eukaryotic pre-mRNA splicing, but pseudogenes like RNU6-1271P are non-functional by definition. There is no evidence this pseudogene is involved in cancer, inflammation, or other disease roles, nor does it interact with drugs or function in molecular pathways. RNU6-1271P should not be used as a synonym for genuine U6 snRNA targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1271, pseudogene (RNU6-1271P).